Monograph
C09CA02 - Eprosartan |
Not porphyrinogenic |
NP |
Rationale
Poorly absorbed, not metabolised.
Chemical description
Angiotensin II receptor antagonist. Weak inhibitor of CYP 2C9 in vitro. Biovailability only 13 % dependent on poor absorbtion. Excreted in unchanged form.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
References
Tradenames
Teveten 
Teveten 
Eprosartan · Futuran · Navixen · Regulaten · Tevetens 
Teveten 
Tevetenz 
Eprosartan · Teveten 
Teveten 
Teveten 
Teveten 
Teveten 
Teveten 
Teveten 
Eprosartan